Kopcalic K, Matic I, Besu I, Stankovic V, Bukumiric Z, Stanojkovic T
BMC Cancer. 2022; 22(1):1167.
PMID: 36368974
PMC: 9652872.
DOI: 10.1186/s12885-022-10255-6.
Sliwinska-Mosson M, Wadowska K, Trembecki L, Bil-Lula I
J Pers Med. 2020; 10(3).
PMID: 32722546
PMC: 7565537.
DOI: 10.3390/jpm10030072.
Patel P, Malipatlolla D, Devarakonda S, Bull C, Rascon A, Nyman M
Nutrients. 2020; 12(8).
PMID: 32707913
PMC: 7468988.
DOI: 10.3390/nu12082172.
Bai L, Zhou B, Zhao Y
Cancer Manag Res. 2019; 11:7925-7931.
PMID: 31686908
PMC: 6709788.
DOI: 10.2147/CMAR.S209286.
Singh J, Sohal S, Lim A, Duncan H, Thachil T, De Ieso P
Ann Transl Med. 2019; 7(11):245.
PMID: 31317015
PMC: 6603343.
DOI: 10.21037/atm.2019.05.31.
Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity?.
Wirsdorfer F, de Leve S, Jendrossek V
Int J Mol Sci. 2018; 20(1).
PMID: 30577587
PMC: 6337556.
DOI: 10.3390/ijms20010024.
Anticancer therapy and lung injury: molecular mechanisms.
Li L, Mok H, Jhaveri P, Bonnen M, Sikora A, Eissa N
Expert Rev Anticancer Ther. 2018; 18(10):1041-1057.
PMID: 29996062
PMC: 6290681.
DOI: 10.1080/14737140.2018.1500180.
A multiobjective Bayesian networks approach for joint prediction of tumor local control and radiation pneumonitis in nonsmall-cell lung cancer (NSCLC) for response-adapted radiotherapy.
Luo Y, McShan D, Matuszak M, Ray D, Lawrence T, Jolly S
Med Phys. 2018; .
PMID: 29862533
PMC: 6279602.
DOI: 10.1002/mp.13029.
Functional promoter rs189037 variant of is associated with decrease in lung diffusing capacity after irradiation for non-small-cell lung cancer.
Lopez Guerra J, Song Y, Nguyen Q, Gomez D, Liao Z, Xu T
Chronic Dis Transl Med. 2018; 4(1):59-66.
PMID: 29756124
PMC: 5938288.
DOI: 10.1016/j.cdtm.2018.02.006.
Modeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades.
Wirsdorfer F, Jendrossek V
Radiat Oncol. 2017; 12(1):142.
PMID: 28836991
PMC: 5571607.
DOI: 10.1186/s13014-017-0865-1.
Immunological Aspect of Radiation-Induced Pneumonitis, Current Treatment Strategies, and Future Prospects.
Kainthola A, Haritwal T, Tiwari M, Gupta N, Parvez S, Tiwari M
Front Immunol. 2017; 8:506.
PMID: 28512460
PMC: 5411429.
DOI: 10.3389/fimmu.2017.00506.
Unraveling biophysical interactions of radiation pneumonitis in non-small-cell lung cancer via Bayesian network analysis.
Luo Y, El Naqa I, McShan D, Ray D, Lohse I, Matuszak M
Radiother Oncol. 2017; 123(1):85-92.
PMID: 28237401
PMC: 5386796.
DOI: 10.1016/j.radonc.2017.02.004.
The Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the Lung.
Wirsdorfer F, Jendrossek V
Front Immunol. 2016; 7:591.
PMID: 28018357
PMC: 5155013.
DOI: 10.3389/fimmu.2016.00591.
MMP-1 promoter polymorphism is associated with risk of radiation-induced lung injury in lung cancer patients treated with radiotherapy.
Liu B, Yi M, Tang Y, Liu Q, Qiu H, Zou Y
Oncotarget. 2016; 7(43):70175-70184.
PMID: 27659527
PMC: 5342544.
DOI: 10.18632/oncotarget.12164.
Genetic variants in the ITGB6 gene is associated with the risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy.
Yi M, Tang Y, Liu B, Li Q, Zhou X, Yu S
Tumour Biol. 2015; 37(3):3469-77.
PMID: 26449830
DOI: 10.1007/s13277-015-4171-y.
NRF2/miR-140 signaling confers radioprotection to human lung fibroblasts.
Duru N, Gernapudi R, Zhang Y, Yao Y, Lo P, Wolfson B
Cancer Lett. 2015; 369(1):184-91.
PMID: 26300493
PMC: 4892935.
DOI: 10.1016/j.canlet.2015.08.011.
Predictive factors for acute radiation pneumonitis in postoperative intensity modulated radiation therapy and volumetric modulated arc therapy of esophageal cancer.
Zhao Y, Chen L, Zhang S, Wu Q, Jiang X, Zhu H
Thorac Cancer. 2015; 6(1):49-57.
PMID: 26273335
PMC: 4448459.
DOI: 10.1111/1759-7714.12142.
Modulation expression of tumor necrosis factor α in the radiation-induced lung injury by glycyrrhizic acid.
Refahi S, Pourissa M, Zirak M, Hadadi G
J Med Phys. 2015; 40(2):95-101.
PMID: 26170556
PMC: 4478651.
DOI: 10.4103/0971-6203.158689.
Therapeutic effects of C-28 methyl ester of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO-Me; bardoxolone methyl) on radiation-induced lung inflammation and fibrosis in mice.
Wang Y, Zhang C, Ma Y, He Z, Zhe H, Zhou S
Drug Des Devel Ther. 2015; 9:3163-78.
PMID: 26124639
PMC: 4482372.
DOI: 10.2147/DDDT.S80958.
Effect of transforming growth factor-β1 869C/T polymorphism and radiation pneumonitis.
Wang Y, Wang X, Wang X, Zhang D, Jiang S
Int J Clin Exp Pathol. 2015; 8(3):2835-9.
PMID: 26045792
PMC: 4440101.
